Richard Kauffman, MD
Internal Medicine · Oglethorpe, GANPI 1679627905
Payments from drug & device makers
Across 286 payments — averaging $23.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Orthopedics LLC$1K
- Gilead$995
- AbbVie$842
- Viiv Healthcare Company$524
- Takeda Pharmaceuticals U.S.A., Inc.$324
- Kerecis Limited$294
- plus $3K from 32 others
What the payments were for
- Food & beverage$5,59782%
- Education$1,20718%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| United Orthopedics LLC | 1 | $1,200 |
| Gilead | 52 | $995 |
| AbbVie(2 entities) | 48 | $842 |
| Viiv Healthcare Company | 30 | $524 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $324 |
| Kerecis Limited | 4 | $294 |
| Lilly USA, LLC | 15 | $273 |
| Novo Nordisk | 13 | $265 |
| Amgen | 16 | $248 |
| AstraZeneca | 11 | $170 |
| Axogen | 1 | $169 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $166 |
| Pfizer | 8 | $135 |
| Sanofi-aventis U.S. LLC | 4 | $119 |
| Merck | 7 | $110 |
| GSK | 6 | $108 |
| Eisai Inc. | 6 | $100 |
| Boston Scientific | 1 | $98 |
| Boehringer Ingelheim | 5 | $93 |
| Biohaven Pharmaceuticals, Inc. | 5 | $84 |
| Exact Sciences | 4 | $75 |
| Kowa Pharmaceuticals America, Inc. | 4 | $46 |
| Johnson & Johnson(2 entities) | 2 | $36 |
| Tris Pharma Inc | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Baxter Healthcare | 1 | $31 |
| Abbott | 1 | $25 |
| Triad Life Sciences Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $24 |
| Genentech USA, Inc. | 1 | $23 |
| Bayer | 1 | $22 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
| Novartis | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Echosens North America, Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,804 in reported general payments places this provider in the 90th percentile of 3,311 internal medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 19 | $346 |
| FenofibrateFenofibrate Nanocrystallized | 12 | $286 |
| Levothyroxine Sodium | 20 | $233 |
| Potassium Chloride | 12 | $193 |
| Amlodipine Besylate | 39 | $192 |
| Pantoprazole Sodium | 16 | $150 |
| Lisinopril | 28 | $140 |
| Atorvastatin Calcium | 33 | $132 |
| Losartan Potassium | 17 | $127 |
| Quetiapine Fumarate | 15 | $107 |
| Simvastatin | 16 | $105 |
| Methylprednisolone | 14 | $98 |
| Allopurinol | 19 | $89 |
| Tramadol Hcl | 19 | $88 |
| Carvedilol | 17 | $76 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Oglethorpe
- Paul BradleySavannah$76.4M
- Kimball JohnsonAtlanta$51.1M
- Bram WieskopfWoodstock$21.9M
- Dwight BlakeUnion City$13.3M
- Charlotte Grayson-MathisFayetteville$9.6M
- Christopher RecknorGainesville$9.2M
- James HarperJohns Creek$9.2M
- Robert Springer IiiAtlanta$5.3M
- Thomas MoriaritySavannah$4.6M
- Charles KempAlbany$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.